Skip to main content

Table 3 Linear regression analyses of factors associated with FFI total score at 26 weeks follow-up

From: Can we predict which patients with plantar heel pain are more likely to benefit from insoles? A secondary exploratory analysis of a randomized controlled trial

 

Patients treated with insoles (custom + sham)

 
 

Univariate

Multivariable model

Variables

Unstandardized β (95% CI)

Unstandardized β (95% CI)

Standardized Beta

Body Mass Index (kg/m2)

1.25 (0.53, 1.98)*

0.69 (−0.05, 1.43)

0.16

Comorbidities (present)

−3.43 (− 13.67, 6.81)

−3.86 (− 13.87, 6.15)

− 0.06

Sex (female)

−0.38 (−9.05,8.29)

−9.59 (− 17.87,-1.31)*

0.19

Age (years)

0.08 (− 0.32, 0,47)

0.27 (− 0.13, 0.67)

0.12

Bilateral pain (no)

−13.05 (−22.62, − 3.47)*

−8.41 (− 18.31, 1.50)

0.15

Neuropathic pain DN4 total score (0–10)

15.27 (6.75, 23.78)*

− 0.21 (− 2.34, 1.92)

− 0.02

Upper ankle joint dorsal range of motion (degrees)

− 0.10 (− 0.37, 0.16)

0.02 (− 0.25, 0.28)

0.01

Metatarsal phalangeal joint dorsal range of motion (degrees)

0.06 (− 0.13, 0,24)

0.08 (− 0.08, 0.24)

0.08

Navicular drop (millimeter)

−4.73 (− 14.74, 5.29)

− 3.62 (− 13.12, 5.87)

−0.07

Activity score (SQUASH)

0.0 (0.00, 0.00)

0.00 (0.00, 0.00)

0.10

Treatment group (custom insole)

0.36 (−7.64, 8.35)

0.59 (− 7.11, 8.30)

0.01

Baseline FFI total score (0–100)

0.63 (0.43, 0.84)*

0.56 (0.30, 0.82)*

0.43

Baseline first step pain (0–10)

2.04 (0.30, 3.78)*

−0.01 (− 1.89, 1.70)

− 0.01

Duration of symptoms (months)

0.25 (− 0.09, 0.59)

0.05 (− 0.30, 0.40)

0.02

Foot posture index (supination)

0.05 (−13.45, 13.55)

−1.14 (− 13.68, 11.39)

− 0.02

Foot posture index (pronation)

5.07 (− 3.79, 13.93)

1.32 (−7.35, 10.00)

0.03

  1. *p-value < 0.05
  2. In the patients treated with usual care only variables that gave a significant result in the patients treated with insoles were analyzed